ADAR1 Capital Management, LLC
10% owner
- Shares
- 331,979
- Price
- $1.66
- Value
- $550,687
TENX
5 buyers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 9 CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
+$6,396,312
5 buyers · 0 sellers
12-month purchases
$6,600,779
8 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
29
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
9 executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TENX overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The aggregate exercise price was paid in cash. The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment. The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on January 9, 2027, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment. The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on May 16, 2026, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment. The options vested and became exercisable as follows: 25% of the underlying shares of common stock vested and became exercisable on each of June 9, 2023, June 9, 2024, June 9, 2025, and June 9, 2026, subject to the Reporting Person's continued employment. The options vested and became exercisable as follows: 25% of the underlying shares of common stock vested and became exercisable on each of July 6, 2022, July 6, 2023, July 6, 2024, and July 6, 2025, subject to the Reporting Person's continued employment.
Voluntary purchases and sales; administrative noise stays hidden.
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
Doogan Declan
Director
Giordano Christopher Thomas
CEO
Giordano Christopher Thomas
CEO
STAAB THOMAS R II
Chief Financial Officer
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
ADAR1 Capital Management, LLC
10% owner
Rich Stuart
Chief Medical Officer
Rich Stuart
Chief Medical Officer
Rich Stuart
Chief Medical Officer
Rich Stuart
Chief Medical Officer
Rich Stuart
Chief Medical Officer
Giordano Christopher Thomas
CEO
Giordano Christopher Thomas
CEO
Giordano Christopher Thomas
CEO
Almenoff June Sherie
Director
Almenoff June Sherie
Director
MCGAULEY THOMAS
Interim CFO
MCGAULEY THOMAS
Interim CFO
MCGAULEY THOMAS
Interim CFO
Almenoff June Sherie
Director
Almenoff June Sherie
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 331,979 | $1.66 | $550,687 | |
| Oct 20, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 254,342 | $1.60 | $405,726 | |
| Oct 19, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 336,528 | $1.51 | $507,013 | |
| Sep 16, 2026 | Doogan Declan Director | Purchase | 53,000 | $1.92 | $101,760 | |
| Sep 15, 2026 | Giordano Christopher Thomas CEO | Purchase | 4,850 | $1.82 | $8,837 | |
| Sep 11, 2026 | Giordano Christopher Thomas CEO | Purchase | 6,000 | $1.88 | $11,250 | |
| Sep 11, 2026 | STAAB THOMAS R II Chief Financial Officer | Purchase | 5,675 | $1.94 | $10,981 | |
| Sep 03, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 900,000 | $1.78 | $1,604,160 | |
| Sep 02, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 187,704 | $1.80 | $337,586 | |
| Sep 01, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 179,058 | $1.80 | $321,570 | |
| Aug 31, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 403,571 | $1.79 | $722,594 | |
| Aug 24, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 107,374 | $1.75 | $188,355 | |
| Aug 21, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 716,369 | $1.77 | $1,266,254 | |
| Aug 20, 2026 | ADAR1 Capital Management, LLC 10% owner | Purchase | 202,124 | $1.78 | $359,538 | |
| Dec 09, 2025 | Rich Stuart Chief Medical Officer | Purchase | 2,500 | $10.22 | $25,542 | |
| Dec 08, 2025 | Rich Stuart Chief Medical Officer | Purchase | 2,500 | $10.10 | $25,251 | |
| Dec 04, 2025 | Rich Stuart Chief Medical Officer | Purchase | 2,500 | $9.20 | $22,998 | |
| Dec 03, 2025 | Rich Stuart Chief Medical Officer | Purchase | 1,500 | $9.08 | $13,618 | |
| Dec 02, 2025 | Rich Stuart Chief Medical Officer | Purchase | 1,000 | $9.01 | $9,006 | |
| Nov 20, 2025 | Giordano Christopher Thomas CEO | Purchase | 538 | $7.59 | $4,083 | |
| Nov 19, 2025 | Giordano Christopher Thomas CEO | Purchase | 455 | $7.51 | $3,417 | |
| Nov 18, 2025 | Giordano Christopher Thomas CEO | Purchase | 1,612 | $7.75 | $12,500 | |
| Nov 18, 2025 | Almenoff June Sherie Director | Purchase | 1,900 | $7.52 | $14,280 | |
| Nov 18, 2025 | Almenoff June Sherie Director | Purchase | 1,900 | $7.52 | $14,280 | |
| Nov 17, 2025 | MCGAULEY THOMAS Interim CFO | Purchase | 5,000 | $7.23 | $36,140 | |
| Nov 17, 2025 | MCGAULEY THOMAS Interim CFO | Purchase | 1,000 | $7.35 | $7,350 | |
| Nov 17, 2025 | MCGAULEY THOMAS Interim CFO | Purchase | 2,000 | $7.34 | $14,674 | |
| Nov 17, 2025 | Almenoff June Sherie Director | Purchase | 93 | $7.15 | $664.95 | |
| Nov 17, 2025 | Almenoff June Sherie Director | Purchase | 93 | $7.15 | $664.95 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.